Drugs / A2NTX

Trials 1

20142015201620172018201920202021202220232024202520262027
PhaseRegistry idDatesIndicationSponsorStatusOutcome
Phase 2/3 NCT01910363 Jul 2013 → Jan 2014 — University of Tokushima Unknown No outcome recorded

Evidence & citations 4 cited values

Every value below carries the sentence it was read from. 1 source stands behind the page.

FieldValueCited text
Known as A2NTX ClinicalTrials.gov intervention name — accepted as the source's own label NCT01910363 ↗
Known as A2NTX:low molecular weight (150kDalton) purified botulinum toxin type A2 preparation “A2NTX:low molecular weight (150kDalton) purified botulinum toxin type A2 preparation” NCT01910363 ↗
Modality Protein / enzyme biologic “botulinum toxin preparation” NCT01910363 ↗
Route Intramuscular “Intramuscular injection of the botulinum toxin preparation” NCT01910363 ↗